NewsRx

Search our medical news database

Industry News (HRT)

Tissue-Selective Progestin Compounds Discovered

Published in Women's Health Weekly, June 29th, 1998

Scientists from Ligand Pharmaceuticals, Inc., have discovered "designer" progestins that show a protective activity in the uterus without concomitant stimulation of breast cell growth.

Research involved in the discovery was published in the June 23, 1998, issue of Journal of Medicinal Chemistry. Two novel, non-steroidal, progestin compounds, (S)-LG120746 and (S)-LG120747, were described that were tested in animal models and demonstrated the ability to selectively stimulate tissues within the body.

Currently available steroidal progestins, most often used in hormone replacement therapy (HRT) and birth control, do not exhibit this ability to discern...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook